Equapath Home

What do we do?

Equapath connects hospitals and diagnostic laboratories with trusted organizations that offer advanced AI-driven tissue analysis. We act as a bridge that helps pathologists in underserved and resource-limited settings access tools, data, and collaborations that are often out of reach.

By linking standard H&E slide data to established AI partners, Equapath enables clinicians to uncover deeper tumor and immune insights without requiring expensive infrastructure or on-site molecular testing.

This platform enables equitable access, improves collaboration between labs and AI innovators, and helps to ensure that every pathologist, anywhere in the world, can benefit from next-generation analytics.

Who do we serve?

Pathologists & Labs

Equapath connects pathologists in underserved and resource-limited communities with trusted organizations that provide advanced AI-based tissue and biomarker analysis.
Our role is to help community and rural pathologists access the same level of digital and spatial tools available in leading research and academic centers.
By bridging this gap, Equapath empowers local labs to deliver faster, data-driven insights, improving diagnostic precision and patient care, regardless of geography or resources.

Collaborative Access

Equapath connects pathologists in underserved and resource-limited settings with AI imaging organizations and research collaborators.

Our goal is to make advanced diagnostic insights accessible, by linking hospitals and labs to open AI tools, shared datasets, and training resources that turn existing digital slides into new opportunities for discovery.

Through these collaborations, Equapath helps expand diagnostic capacity, foster knowledge exchange, and bring equitable innovation to clinical and research environments worldwide.

Researchers

Equapath enables researchers in oncology and pathology to collaborate with global partners and access high-quality spatial imaging analysis from diverse populations.

Through our network, researchers can expand their studies beyond traditional academic hubs. We support academic and clinical investigators with access to advanced image analysis, AI-powered biomarker quantification, and spatial mapping of the tumor microenvironment (TME), accelerating discovery and making research more inclusive and impactful.

Equapath helps academic and industry researchers collaborate with pathologists in underserved and resource-limited settings.

Through our network, researchers can access more diverse datasets, validate AI imaging models in real-world clinical contexts, and expand the inclusivity of biomedical studies. We facilitate connections, shared data resources, and communication pipelines that make research both globally representative and socially impactful.

By bridging AI imaging innovation with under-resourced labs, Equapath enables discovery that is more equitable, reproducible, and collaborative across borders.

Technology – AI-driven Collaboration

Equapath connects pathologists and researchers with trusted AI imaging tools co-developed and validated through partnerships with experts at UPMC and PredxBio.

We connect pathologists in resource-limited settings with leading AI platforms that analyze digitized H&E slides to uncover biological insights, helping them participate in cutting-edge research and discovery.

Equapath bridges research innovation and tries to further empower teams to bring AI-driven pathology within reach of every lab.

About Equapath

Equapath empowers clinicians and researchers to see what others miss — anywhere, anytime.
By transforming standard H&E slides into molecularly rich, AI-driven insights, Equapath makes precision pathology faster, more affordable, and more accessible for every community.

It all begins with access
The story of Equapath began with a simple question: What if advanced pathology could reach every corner of the world? After two years of research at UPMC Hillman Cancer Center, our founder saw firsthand how AI and digital pathology could uncover patterns invisible to the human eye — but also how many hospitals and labs lacked access to these transformative tools.

That experience led to the creation of Equapath, a nonprofit initiative designed to democratize computational pathology. By partnering with PredxBio, we developed a secure, cloud-based platform that allows hospitals, academic labs, and clinicians to upload routine pathology images and receive AI-powered biomarker insights in minutes — not days.

Our mission

Equapath’s mission is to bridge the gap between advanced diagnostics and underserved regions by combining the power of AI, pathology, and global collaboration. We believe that cutting-edge analysis should not depend on geography or infrastructure. Every image holds potential — and every patient deserves the chance for early, precise diagnosis.

Our vision

We envision a world where no lab is left behind — where every slide tells a deeper story, and where digital insight drives better treatment decisions, faster drug development, and more equitable healthcare outcomes worldwide.

Our Team

Reina Majumdar

Reina Majumdar is a senior at Lansdale Catholic High School in Pennsylvania whose interests lie at the intersection of computing, biology, and community impact. Through two summer research internships at the UPMC Hillman Cancer Center, she explored how AI and data science can uncover biological insights—studying the effects of BAP1 mutations on mesothelioma survival and analyzing gene-expression changes after heart attacks. These experiences inspired her to found Equapath, an early-stage venture connecting AI-powered pathology research with underserved healthcare communities.

Dr Aman Khera

AegisCare was founded by Dr. Aman Khera, a third-generation physician with over 25 years of experience in healthcare, driven by a belief that care should be equitable, affordable, and accessible for all. After decades of practice, he witnessed firsthand how India’s elderly often struggled to navigate hospitals alone or avoided care due to cost and complexity. Inspired to change this, he launched AegisCare—a technology-enabled eldercare platform that blends compassion with innovation. By leveraging his nationwide medical network, Dr. Khera is building a system that offers affordable preventive care, remote monitoring, and peace of mind for families worldwide.

Bridging Spatial Imaging and AI Analysis to Underserved Pathologists